Journal of autoimmunity
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study.
Dario Roccatello, Alice Barinotti, Massimo Radin, Irene Cecchi, Elena Rubini, Daniele Mancardi, Martina Cozzi, Roberta Fenoglio, Savino Sciascia
Published: 202510.1016/j.jaut.2025.103520
Abstract
Refractory lupus nephritis (LN) poses a significant clinical challenge in the management of systemic lupus erythematosus (SLE) due to its resistance to conventional immunosuppressive therapies. This study evaluates the immunological, anti-inflammator…
Preview only. Read the full abstract at the source